2021
Temporal Changes and Institutional Variation in Use of Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction With Multivessel Coronary Artery Disease in the United States
Secemsky EA, Butala N, Raja A, Khera R, Wang Y, Curtis JP, Maddox TM, Virani SS, Armstrong EJ, Shunk KA, Brindis RG, Bhatt D, Yeh RW. Temporal Changes and Institutional Variation in Use of Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction With Multivessel Coronary Artery Disease in the United States. JAMA Cardiology 2021, 6: 574-580. PMID: 33146666, PMCID: PMC7643043, DOI: 10.1001/jamacardio.2020.5354.Peer-Reviewed Original ResearchMeSH KeywordsAgedCoronary StenosisDrug-Eluting StentsFemaleHumansMaleMiddle AgedPercutaneous Coronary InterventionPractice Patterns, Physicians'RegistriesST Elevation Myocardial InfarctionUnited StatesConceptsMV-percutaneous coronary interventionST-elevation myocardial infarctionMultivessel percutaneous coronary interventionPercutaneous coronary interventionMajor epicardial vesselsPCI useMV diseaseCoronary interventionIndex procedureMyocardial infarctionSTEMI admissionsEpicardial vesselsNational Cardiovascular Data Registry CathPCI RegistryIndex percutaneous coronary interventionMore major epicardial vesselsMultivessel coronary artery diseaseCoronary stentsSmall randomized studiesDays of dischargeCoronary artery diseaseMinority of patientsIndex admissionNonculprit lesionsCathPCI RegistryComplete revascularization
2020
Facility Variation in Troponin Ordering Within the Veterans Health Administration
Chui PW, Esserman D, Bastian LA, Curtis JP, Gandhi PU, Rosman L, Desai N, Hauser RG. Facility Variation in Troponin Ordering Within the Veterans Health Administration. Medical Care 2020, 58: 1098-1104. PMID: 33003051, PMCID: PMC7666100, DOI: 10.1097/mlr.0000000000001424.Peer-Reviewed Original ResearchMeSH KeywordsAcute Coronary SyndromeAge FactorsAgedAged, 80 and overComorbidityCross-Sectional StudiesDiagnosis-Related GroupsEmergency Service, HospitalGuideline AdherenceHumansMiddle AgedPractice Guidelines as TopicPractice Patterns, Physicians'Sex FactorsSocioeconomic FactorsTroponinUnited StatesUnited States Department of Veterans AffairsConceptsDownstream resource utilizationVeterans Health AdministrationCase mixHealth AdministrationCurrent United States guidelinesDownstream health care utilizationVeterans Health Administration facilitiesFacility characteristicsAcute coronary syndromeEmergency department visitsPercutaneous coronary interventionHealth care utilizationAcute care facilitiesUnited States guidelinesHigh rateCross-sectional analysisCoronary syndromeCoronary interventionED visitsDepartment visitsCare utilizationHighest quartileCoronary angiogramInpatient admissionsLowest quartileDuration of P2Y12 inhibitor Prescription After Percutaneous Coronary Intervention in Patients on Oral Anticoagulants (from NCDR CathPCI Registry)
Saad M, Tobolski J, Kolte D, Wang Y, Minges K, Hira RS, Curtis JP, Abbott JD. Duration of P2Y12 inhibitor Prescription After Percutaneous Coronary Intervention in Patients on Oral Anticoagulants (from NCDR CathPCI Registry). The American Journal Of Cardiology 2020, 133: 182-184. PMID: 32819682, DOI: 10.1016/j.amjcard.2020.07.029.Peer-Reviewed Original Research
2019
Association of Physician Specialty With Long-Term Implantable Cardioverter-Defibrillator Complication and Reoperations Rates
Chui PW, Wang Y, Ranasinghe I, Mitiku TY, Seto AH, Rosman L, Lampert R, Minges KE, Enriquez AD, Curtis JP. Association of Physician Specialty With Long-Term Implantable Cardioverter-Defibrillator Complication and Reoperations Rates. Circulation Cardiovascular Quality And Outcomes 2019, 12: e005374. PMID: 31185734, PMCID: PMC7412734, DOI: 10.1161/circoutcomes.118.005374.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overClinical CompetenceDefibrillators, ImplantableElectric CountershockFee-for-Service PlansFemaleHumansIncidenceMaleMedicarePostoperative ComplicationsPractice Patterns, Physicians'RegistriesReoperationRisk AssessmentRisk FactorsSpecializationTime FactorsTreatment OutcomeUnited StatesConceptsLong-term device-related complicationsDevice-related complicationsICD implantationLong-term outcomesPhysician specialtyGeneral cardiologistsThoracic surgeonsHigh riskNational Cardiovascular Data Registry ICD RegistryLong-term adverse outcomesImplantable cardioverter defibrillator implantationPhysician specialty trainingCardioverter-defibrillator implantationCumulative incidence rateCase-mix adjusted ratesReoperation rateBackground PatientsConclusions PatientsICD RegistryPrimary outcomeAdverse outcomesIncidence rateInterventional cardiologistsAdjusted ratesReoperation
2018
Association of the US Department of Justice Investigation of Implantable Cardioverter-Defibrillators and Devices Not Meeting the Medicare National Coverage Determination, 2007-2015
Desai NR, Bourdillon PM, Parzynski CS, Brindis RG, Spatz ES, Masters C, Minges KE, Peterson P, Masoudi FA, Oetgen WJ, Buxton A, Zipes DP, Curtis JP. Association of the US Department of Justice Investigation of Implantable Cardioverter-Defibrillators and Devices Not Meeting the Medicare National Coverage Determination, 2007-2015. JAMA 2018, 320: 63-71. PMID: 29971398, PMCID: PMC6583049, DOI: 10.1001/jama.2018.8151.Peer-Reviewed Original ResearchConceptsPrimary prevention ICDsNon-Medicare beneficiariesAbsolute decreaseNational Cardiovascular Data Registry ICD RegistrySerial cross-sectional analysisStudy periodImplantable cardioverter defibrillatorRelative decreaseCross-sectional analysisProportion of devicesInitial ICDICD RegistryPrimary preventionCardioverter defibrillatorMAIN OUTCOMEMedicare beneficiariesUS hospitalsHospital groupHospitalICDMore rapid decreasesModest decreaseDepartmentMedicareUS DepartmentComparison of Physician Visual Assessment With Quantitative Coronary Angiography in Assessment of Stenosis Severity in China
Zhang H, Mu L, Hu S, Nallamothu BK, Lansky AJ, Xu B, Bouras G, Cohen DJ, Spertus JA, Masoudi FA, Curtis JP, Gao R, Ge J, Yang Y, Li J, Li X, Zheng X, Li Y, Krumholz HM, Jiang L. Comparison of Physician Visual Assessment With Quantitative Coronary Angiography in Assessment of Stenosis Severity in China. JAMA Internal Medicine 2018, 178: 239-247. PMID: 29340571, PMCID: PMC5838612, DOI: 10.1001/jamainternmed.2017.7821.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overChinaCoronary AngiographyCoronary StenosisCoronary VesselsCross-Sectional StudiesFemaleFollow-Up StudiesHumansIncidenceMaleMiddle AgedPercutaneous Coronary InterventionPractice Patterns, Physicians'Predictive Value of TestsProspective StudiesRisk AssessmentSeverity of Illness IndexTime FactorsConceptsPhysician visual assessmentPercutaneous coronary interventionAcute myocardial infarctionQuantitative coronary angiographyStenosis severityCoronary angiographyMean agePCI studiesMean percent diameter stenosisIndependent core laboratoryPercent diameter stenosisCross-sectional studyNon-AMI patientsStandard clinical practiceFractional flow reserveSubset of participantsQCA assessmentCoronary revascularizationMore stenosisCoronary interventionCoronary lesionsChina PatientCoronary angiogramDiameter stenosisMyocardial infarction
2017
Use of Cardiac Resynchronization Therapy Among Eligible Patients Receiving an Implantable Cardioverter Defibrillator: Insights From the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry
Marzec LN, Peterson PN, Bao H, Curtis JP, Masoudi FA, Varosy PD, Bradley SM. Use of Cardiac Resynchronization Therapy Among Eligible Patients Receiving an Implantable Cardioverter Defibrillator: Insights From the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry. JAMA Cardiology 2017, 2: 561-565. PMID: 28122073, PMCID: PMC5814986, DOI: 10.1001/jamacardio.2016.5388.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overAtrial FibrillationBlack or African AmericanBundle-Branch BlockCardiac Resynchronization TherapyCardiac Resynchronization Therapy DevicesCerebrovascular DisordersCohort StudiesComorbidityDefibrillators, ImplantableDiabetes MellitusEthnicityFemaleHealth Facility SizeHeart FailureHospitalsHospitals, TeachingHumansHypertensionInsurance, HealthLung DiseasesMaleMedicaidMedicareMiddle AgedMortalityMyocardial IschemiaPractice Patterns, Physicians'RegistriesRegression AnalysisRetrospective StudiesUnited StatesWhite PeopleConceptsUse of CRTCardiac resynchronization therapyCRT-D useImplantable cardioverter defibrillatorGuideline-eligible patientsDevice implantationEligible patientsResynchronization therapyCardioverter defibrillatorNational Cardiovascular Data Registry Implantable Cardioverter Defibrillator RegistryNational Cardiovascular Data Registry ICD RegistryHeart failure-related eventsImplantable Cardioverter-Defibrillator RegistryCRT-D groupMulticenter retrospective cohortRisk-standardized ratesHospital-level variationCRT-D devicesHierarchical multivariable modelNonprivate insuranceRetrospective cohortSelect patientsICD RegistryGuideline recommendationsICD placementTemporal Trends in and Factors Associated With Use of Single- Versus Dual-Coil Implantable Cardioverter-Defibrillator Leads Data From the NCDR ICD Registry
Pokorney SD, Parzynski CS, Daubert JP, Hegland DD, Varosy PD, Curtis JP, Al-Khatib SM. Temporal Trends in and Factors Associated With Use of Single- Versus Dual-Coil Implantable Cardioverter-Defibrillator Leads Data From the NCDR ICD Registry. JACC Clinical Electrophysiology 2017, 3: 612-619. PMID: 29759435, DOI: 10.1016/j.jacep.2016.11.014.Peer-Reviewed Original ResearchMeSH KeywordsArrhythmias, CardiacDefibrillators, ImplantableFemaleHospitalsHumansMaleMiddle AgedPractice Patterns, Physicians'RegistriesUnited StatesConceptsDual-coil ICD leadsICD RegistryNational Cardiovascular Data Registry ICD RegistryICD leadHospital-level factorsDual-coil leadsNCDR ICD RegistrySingle-coil leadsDual-coil ICDHigh-use groupPatient characteristicsPatient factorsPatient groupPatient outcomesImplantable cardioverterMore ICDsLower mortalityPre-specified groupsHospitalICDStatistical differenceUse of SingleTemporal trendsSignificant differencesRegistry
2014
Patterns and Outcomes of Red Blood Cell Transfusion in Patients Undergoing Percutaneous Coronary Intervention
Sherwood MW, Wang Y, Curtis JP, Peterson ED, Rao SV. Patterns and Outcomes of Red Blood Cell Transfusion in Patients Undergoing Percutaneous Coronary Intervention. JAMA 2014, 311: 836-843. PMID: 24570247, PMCID: PMC4276400, DOI: 10.1001/jama.2014.980.Peer-Reviewed Original ResearchConceptsPercutaneous coronary interventionRed blood cell transfusionReceipt of transfusionBlood cell transfusionAssociation of transfusionMyocardial infarctionTransfusion rateCell transfusionCoronary interventionTransfusion practiceHospital coronary artery bypass graft surgeryCoronary artery bypass graft surgeryHospital adverse cardiac eventsArtery bypass graft surgeryAdvanced renal dysfunctionPrior heart failureRisk-standardized ratesAdverse cardiac eventsBypass graft surgeryRetrospective cohort studyAcute coronary syndromeAdverse cardiac outcomesPrior myocardial infarctionBlood transfusion practicesCurrent transfusion practices
2013
Patient, Physician, and Procedural Factors Influencing the Use of Defibrillation Testing during Initial Implantable Cardioverter Defibrillator Insertion: Findings from the NCDR®
RUSSO AM, WANG Y, AL‐KHATIB S, CURTIS JP, LAMPERT R. Patient, Physician, and Procedural Factors Influencing the Use of Defibrillation Testing during Initial Implantable Cardioverter Defibrillator Insertion: Findings from the NCDR®. Pacing And Clinical Electrophysiology 2013, 36: 1522-1531. PMID: 23981009, DOI: 10.1111/pace.12248.Peer-Reviewed Original ResearchConceptsHospital adverse eventsDFT testingAdverse eventsImplantable cardioverter-defibrillator insertionLeft ventricular ejection fractionCardiac resynchronization therapy devicesPrimary prevention indicationVentricular ejection fractionResynchronization therapy devicesProspective randomized dataImplantable cardioverter defibrillator (ICD) technologyDefibrillation threshold testingPatterns of practiceMore comorbiditiesPrevention indicationDefibrillator insertionEjection fractionHeart failureAtrial arrhythmiasDefibrillation testingIndependent associationProcedural characteristicsTeaching hospitalDefibrillator technologyImplant procedure
2012
Impact of a Recent Lead Recall on Utilization of Implantable Cardioverter Defibrillators: Data from the NCDR ICD Registry™
BHATT P, CURTIS J, WANG Y, LAMPERT R. Impact of a Recent Lead Recall on Utilization of Implantable Cardioverter Defibrillators: Data from the NCDR ICD Registry™. Journal Of Cardiovascular Electrophysiology 2012, 23: 861-865. PMID: 22452744, DOI: 10.1111/j.1540-8167.2012.02310.x.Peer-Reviewed Original ResearchAgedAged, 80 and overDeath, Sudden, CardiacDefibrillators, ImplantableElectric CountershockFemaleHumansMaleMedical Device RecallsMiddle AgedPractice Guidelines as TopicPractice Patterns, Physicians'Primary PreventionProsthesis DesignProsthesis FailureRegistriesRisk AssessmentRisk FactorsTime FactorsUnited States
2011
Concordance of Physician Ratings With the Appropriate Use Criteria for Coronary Revascularization
Chan PS, Brindis RG, Cohen DJ, Jones PG, Gialde E, Bach RG, Curtis J, Bethea CF, Shelton ME, Spertus JA. Concordance of Physician Ratings With the Appropriate Use Criteria for Coronary Revascularization. Journal Of The American College Of Cardiology 2011, 57: 1546-1553. PMID: 21453833, PMCID: PMC3085030, DOI: 10.1016/j.jacc.2010.10.050.Peer-Reviewed Original ResearchMeSH KeywordsFemaleHumansMaleMyocardial RevascularizationPatient SelectionPractice Patterns, Physicians'Non–Evidence-Based ICD Implantations in the United States
Al-Khatib SM, Hellkamp A, Curtis J, Mark D, Peterson E, Sanders GD, Heidenreich PA, Hernandez AF, Curtis LH, Hammill S. Non–Evidence-Based ICD Implantations in the United States. JAMA 2011, 305: 43-49. PMID: 21205965, PMCID: PMC3432303, DOI: 10.1001/jama.2010.1915.Peer-Reviewed Original ResearchMeSH KeywordsAgedCardiologyCohort StudiesCoronary Artery BypassDeath, Sudden, CardiacDefibrillators, ImplantableEvidence-Based MedicineFemaleGuideline AdherenceHeart FailureHospital MortalityHumansMaleMiddle AgedMyocardial InfarctionPatient SelectionPractice Patterns, Physicians'Primary PreventionRegistriesRetrospective StudiesTreatment OutcomeUnited StatesConceptsICD implantsHospital outcomesNational Cardiovascular Data Registry ICD RegistryCoronary artery bypass graft surgerySevere heart failure symptomsArtery bypass graft surgeryBypass graft surgeryHeart failure symptomsRetrospective cohort studyYear of procedureEvidence-based criteriaGraft surgeryHospital deathCohort studyICD implantationHeart failurePostprocedure complicationsPrimary preventionMyocardial infarctionRecent diagnosisFailure symptomsPhysician specialtyPractice guidelinesMAIN OUTCOMEHigh risk
2010
The Relation Between Hospital Procedure Volume and Complications of Cardioverter-Defibrillator Implantation From the Implantable Cardioverter-Defibrillator Registry
Freeman JV, Wang Y, Curtis JP, Heidenreich PA, Hlatky MA. The Relation Between Hospital Procedure Volume and Complications of Cardioverter-Defibrillator Implantation From the Implantable Cardioverter-Defibrillator Registry. Journal Of The American College Of Cardiology 2010, 56: 1133-1139. PMID: 20863954, DOI: 10.1016/j.jacc.2010.07.007.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedCause of DeathDefibrillators, ImplantableFemaleHealth Care SurveysHospital MortalityHospitalsHumansIncidenceMaleMiddle AgedPractice Patterns, Physicians'RegistriesSurvival RateWorkloadConceptsAdverse eventsProcedure volumeImplantable Cardioverter-Defibrillator RegistryHospital adverse outcomesInitial ICD implantationCardioverter-defibrillator implantationHigh-volume hospitalsLow-volume hospitalsPatients' clinical characteristicsBetter clinical outcomesHospital procedure volumeVolume-outcome relationshipNCDR ICD RegistryClinical characteristicsICD implantationICD RegistryProcedural complicationsClinical outcomesAdverse outcomesHospital characteristicsBiventricular ICDsImplant volumeHospitalRepresentative populationICD
2008
Regional Variation in Cardiac Catheterization Appropriateness and Baseline Risk After Acute Myocardial Infarction
Ko DT, Wang Y, Alter DA, Curtis JP, Rathore SS, Stukel TA, Masoudi FA, Ross JS, Foody JM, Krumholz HM. Regional Variation in Cardiac Catheterization Appropriateness and Baseline Risk After Acute Myocardial Infarction. Journal Of The American College Of Cardiology 2008, 51: 716-723. PMID: 18279735, DOI: 10.1016/j.jacc.2007.10.039.Peer-Reviewed Original ResearchConceptsAcute myocardial infarctionCardiac catheterization useBaseline riskCardiac catheterizationMyocardial infarctionCardiology/American Heart Association classificationRisk-standardized mortality ratesAmerican Heart Association classificationCardiac catheterization ratesGRACE risk scoreHigh-risk patientsClass I patientsClass III patientsClass II patientsPatient appropriatenessCatheterization ratesHospital admissionI patientsPrimary outcomeAMI patientsII patientsIII patientsAppropriate indicationsInvasive strategyPhysician characteristics
2005
The Impact of Clinical Trials on the Use of Hormone Replacement Therapy
Kim N, Gross C, Curtis J, Stettin G, Wogen S, Choe N, Krumholz HM. The Impact of Clinical Trials on the Use of Hormone Replacement Therapy. Journal Of General Internal Medicine 2005, 20: 1026-1031. PMID: 16307628, PMCID: PMC1490267, DOI: 10.1111/j.1525-1497.2005.0221.x.Peer-Reviewed Original ResearchMeSH KeywordsAge DistributionAgedClinical Trials as TopicFemaleHormone Replacement TherapyHumansInformation DisseminationInsurance, Pharmaceutical ServicesLongitudinal StudiesMiddle AgedPatient Acceptance of Health CarePractice Patterns, Physicians'Retrospective StudiesTreatment RefusalUnited StatesConceptsWomen's Health InitiativeHormone replacement therapyHRT useHRT discontinuationReplacement therapyHealth initiativesHormone replacement therapy useLocal practice patternsHRT prescriptionHRT usersMarked regional variationPrescription fillingTherapy useClinical behaviorClinical trialsPractice patternsSubstantial geographic variationTrial publicationsDiscontinuationHealth databasesTrial dataAge groupsRapid effectsWest South CentralTrial results
2004
Association Between Functional Status and Use and Effectiveness of Beta‐Blocker Prophylaxis in Elderly Survivors of Acute Myocardial Infarction
Vitagliano G, Curtis JP, Concato J, Feinstein AR, Radford MJ, Krumholz HM. Association Between Functional Status and Use and Effectiveness of Beta‐Blocker Prophylaxis in Elderly Survivors of Acute Myocardial Infarction. Journal Of The American Geriatrics Society 2004, 52: 495-501. PMID: 15066062, DOI: 10.1111/j.1532-5415.2004.52153.x.Peer-Reviewed Original ResearchMeSH KeywordsActivities of Daily LivingAcute DiseaseAdrenergic beta-AntagonistsAge FactorsAgedAged, 80 and overCross-Sectional StudiesDrug PrescriptionsDrug UtilizationFemaleGeriatric AssessmentHumansLogistic ModelsMaleMultivariate AnalysisMyocardial InfarctionPatient DischargePatient SelectionPractice Patterns, Physicians'Proportional Hazards ModelsRetrospective StudiesSurvival AnalysisTreatment OutcomeUnited StatesConceptsAcute myocardial infarctionHospital dischargeFunctional impairmentElderly patientsMyocardial infarctionAcute myocardial infarction survivorsBeta-blocker prescriptionBeta-blocker prophylaxisBeta-blocker treatmentRetrospective cohort studySimilar survival benefitMain outcome measuresMyocardial infarction survivorsAcute care hospitalsEligible patientsCohort studySurvival benefitCare hospitalFunctional statusNational cohortInfarction survivorsOutcome measuresElderly survivorsPatientsCognitive impairment